About Transkript

Transkript

Transkript, styled |transkript with the subtitle Wirtschaft, Technologie, Leben, is the quarterly German trade magazine for biotechnology in business, research, and politics, published by the Biocom AG in Berlin, the life sciences specialist publisher. First issued in 1995, the magazine specializes in biotechnology and biopharma and serves as the official organ of BIO Deutschland, the German Society for Proteome Research (DGPF), and the Biotechnology Student Initiative (btS), the three organizations the Wikipedia article names. The distributed circulation is 10,500 copies in the 2021 media data, with around 4,500 sold copies from subscriptions and member copies and around 5,500 free copies including trade fair copies, the verbreitete Auflage the article records, and the print ISSN is 1435-5272.

Overview

The quarterly rhythm gives the biotechnology industry a reflective specialist pulse: four issues a year, the quartalsweise Erscheinungsweise the article records, each covering the business, the technology, and the life sciences' societal dimension with the depth that the monthly news cycle cannot provide. The distributed circulation of 10,500 copies, in the 2021 media data, splits into around 4,500 sold copies from subscriptions and member copies and around 5,500 free copies including the trade fair copies that reach the industry's event audiences.

The organ function defines the magazine's institutional journalism: as the official Organ of BIO Deutschland, the DGPF, and the btS, Transkript carries the associations' communications to their members and the industry, while its independent editorial coverage serves the broader biotech business, research, and policy readership. The three organizations span the industry's full demographic: the companies, the proteome researchers, and the students.

The subtitle's three words, Wirtschaft, Technologie, Leben, structure the editorial program: the business journalism on the companies, the financings, and the market; the technology journalism on the research, the platforms, and the products; and the Leben dimension on the life sciences' societal, ethical, and political context.

Transkript is the Fachzeitschrift für Biotechnologie in Wirtschaft, Forschung und Politik: the quarterly trade magazine that covers biotechnology and biopharma across the business, research, and policy dimensions. Its subtitle, Wirtschaft, Technologie, Leben, captures the editorial program: the business of biotechnology, the technology, and the life sciences' societal dimension.

The magazine's institutional role is the official organ of three organizations: BIO Deutschland, the industry association of German biotechnology companies; the Deutsche Gesellschaft für Proteomforschung, the German Society for Proteome Research; and the Biotechnologische Studenteninitiative, the biotechnology student initiative. The organ function gives the magazine its direct channel to the industry's companies, researchers, and students.

History

The 1995 founding, the Erstausgabe the article dates, places Transkript in the generation of German biotech media that grew with the federal BioRegio competition and the venture capital wave that created the German biotech industry. The magazine's first decade documented the Neuer Markt era: the IPOs, the boom, and the bust that thinned the industry's ranks and taught the German biotech business its capital market lessons.

The 2000s and 2010s brought the consolidation and the maturation: the surviving companies' path to products and revenues, the BioNTech and Curevac mRNA story, and the current listed-company landscape that the 2025 retrospective surveys with its sobering tableau. The retrospective's company-by-company account, from the MorphoSys-Novartis deal through the Evotec restructuring to the Medigene insolvency and the Curevac-BioNTech acquisition, shows the magazine's analytical depth in covering the industry's capital market dimension.

The Biocom AG's continuity as the Berlin publishing home marks Transkript as an independent specialist publisher's title: the life sciences publishing house that has served the biotech industry alongside its magazine, its industry reports, and its professional events.

Transkript was first issued in 1995, placing its founding in the generation of German biotech media that grew with the BioRegio competition and the Neuer Markt biotech boom of the late 1990s. The Biocom AG in Berlin has been its publishing home, the specialist publisher for the life sciences.

The magazine's three decades have documented German biotechnology's dramatic arc: from the 1990s founding wave through the Neuer Markt boom and bust, the consolidation of the 2000s, and the current listed-company landscape that the magazine's 2025 retrospective surveys. The retrospective's tableau, in Michael Thiel's contribution, shows the thinning ranks of listed German biotech firms in 2024 and 2025: the MorphoSys acquisition by Novartis and the Planegg site's closure, Evotec's share price collapse and restructuring, Formycon's writedown, Immunic's missed primary endpoint, Medigene's insolvency filing, Curevac's acquisition by BioNTech, and the Cardior Pharmaceuticals sale to Novo Nordisk for 1.025 billion euros.

Coverage and Content

The business journalism covers the biotech industry's capital market dimension: the listed companies' fortunes, the acquisitions, the restructurings, and the insolvencies that the 2025 retrospective documents company by company for the börsennotierten deutschen Biotechnologiefirmen. The MorphoSys story, from the Novartis bar offer of 68 euros per share through the 800 million euro special writedown to the Pelabresib program's discontinuation and the Planegg site's closure, shows the magazine's forensic business coverage.

The technology journalism covers the research and product dimension: from the 1980s insulin production on genetically modified organisms through the monoclonal antibody breakthrough to the current RNA platform technologies, the noncoding RNAPlattformtechnologie that justified the Cardior acquisition's billion-euro price. The medtech coverage, in the tag archives, extends to the minimalinvasive surgery agenda: the heart pumps, the surgical robots like the Freiburg systems, the start-up financings, and the cross-border acquisitions.

The policy journalism covers the biotechnology's regulatory and societal context: the Leben dimension of the subtitle that addresses the life sciences' ethical, political, and public dimensions alongside the business and technology coverage for Wirtschaft, Forschung und Politik.

Transkript covers the biotechnology industry's full spectrum: the business developments, the technology, the research, and the policy. The 2025 retrospective on 40 years of German biotechnology shows the editorial depth: from insulin production on genetically modified organisms in the 1980s through the 1998 breakthrough of the first monoclonal antibody Rituximab to the current market consolidation.

The digital news agenda, in the transkript.de tag archives, shows the daily editorial tempo: the minimalinvasive surgery coverage, from the Werner-von-Siemens-Ring for the world's smallest heart pump to the Intuitive Surgical move to Freiburg, the RAYDIAX financing, the Berlin Heals heart microcurrent technology, and the Optimed acquisition from Hong Kong. The biotech business coverage tracks the listed companies' fortunes, the acquisitions, and the restructurings.

Organization and Ownership

Transkript is published by the Biocom AG in Berlin, the specialist publisher for the life sciences and the Herausgeber the article names. The magazine serves as the official organ of BIO Deutschland, the industry association, the Deutsche Gesellschaft für Proteomforschung (DGPF), the proteome researchers, and the Biotechnologische Studenteninitiative (btS), the students.

Current editorial team details are not publicly confirmed in the sources reviewed beyond the publisher; the magazine's public face in the sources is the Biocom AG's Berlin publishing program.

Digital Presence

Transkript.de is the magazine's digital home, with the daily industry news, the tag archives like the minimalinvasiv collection, and the downloadable special contributions such as the 2025 biotechnology retrospective. The site's current news covers the medtech and biotech agenda, from the heart pumps to the start-up financings, alongside the quarterly print magazine.

Dedicated apps or podcasts for the Transkript brand are not detailed in the sources reviewed; the brand's digital presence rests on its website and the quarterly print magazine's biotechnology journalism since 1995.